INMD
InMode Ltd.
NASDAQ · Healthcare · Medical - Devices · IL
$14.07
−0.64%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$14.12
From 52W high−15.34%
Volume387951.00
Market cap$809.65M
P/E (TTM)11.3x
P/S (TTM)2.2x
Div yield—
Key dataOct 19, 2026
Open
$14.12
From 52W high
−15.34%
Volume
387951.00
Market cap
$809.65M
ValuationView details →
P/E (Fwd)
10.4x
EV/EBITDA
3.7x
P/E (TTM)
11.3x
RSI (14)
37.8
MomentumView details →
1D Return
−0.64%
YTD Return
−4.19%
SummaryUpdated Jun 1, 2026
InMode Ltd. (NASDAQ:INMD) is an Israeli medical device company founded in 2008 and headquartered in Yokneam, Israel. The company went public on NASDAQ in August 2019 after changing its name from Invasix Ltd. in 2017. InMode specializes in designing, developing, manufacturing, and marketing minimally invasive and non-invasive aesthetic medical devices based on proprietary radiofrequency technologies. The company has grown to become a significant player in the global aesthetic medical device market, operating in over 80 countries and serving both medical professionals and patients seeking cosmetic treatments.
Similar companies
Latest newsMore news →
InMode announced that it plans to release its third-quarter 2026 financial results before the NASDAQ, INC. market opens on November 11, 2026.7d agoInMode announced that it expects to report third-quarter 2026 revenue of $91.8 million to $92.0 million and reiterated full-year 2026 revenue guidance of $365 million to $375 million.7d agoInMode reported second quarter 2026 GAAP revenues of $95.6 million, consistent with the second quarter of 2025.76d ago